CLINICAL_TRIALS
trial_result
· 2012-08-23
Clinical Trial Update: Epoprostenol for Injection in Pulmonary Arterial Hypertension [Phase 4]
Summary
Phase 4 trial update for Epoprostenol for Injection in pulmonary arterial hypertension. The study has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-08-23